Stock Groups

Britain approves Pfizer’s antiviral Covid-19 pill, Paxlovid

[ad_1]

Britain approves PfizerPatients over 18 who are suffering from mild or moderate infections and at risk for their condition getting worse can take the Covid-19 pill.

It comes amid an unprecedented number of Covid-19-related cases each day, and the nation is scrambling to put its defenses together.

Data shows that Paxlovid works best when used in early Covid-19 stages, according to the Britain’s Medicines and Healthcare products Regulatory Agency.

Pfizer announced this month that Paxlovid had a near 90% success rate in preventing the deaths of high-risk patients. Furthermore, recent laboratory data suggest the drug’s effectiveness in fighting the rapid spreading coronavirus omicron.

We now have an additional antiviral medication for Covid-19, which can be taken orally rather than intravenously. It can also be used outside of a hospital,” June Raine, chief of the MHRA said in a statement.

[ad_2]